July 2026
The global GLP-1 market size was evaluated at USD 58.40 billion in 2025 and is predicted to hit around USD 212.73 billion by 2035, growing at a CAGR of 13.80%.
July 2026
The global GLP-1 analogues market size was evaluated at USD 66.48 billion in 2025 and is predicted to hit around USD 1,062.90 billion by 2035, growing at a CAGR of 31.94%
June 2026
The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.
February 2026
The global obesity GLP-1 market size was evaluated at USD 8.21 billion in 2025 and is predicted to hit around USD 66.57 billion by 2035, growing at a CAGR of 23.28%.